Ensemble Health Partners has completed its $785 million fungible incremental first-lien term loan due August 2026 (L+375, 0% Libor floor) that priced tight of talk at an original issue discount of 99.75 via a Goldman Sachs-led arranger group, according to sources. The term loan, which was upsized by $100 million during syndication, will be used to fund a distribution to shareholders. Additionally, there is an associated amendment for a one-time restricted payments waiver to permit the transaction, and the originally offered consent fee of 12.5 basis points was removed. The rated entity is Ensemble RCM LLC. Ensemble Health, backed by Golden Gate Capital, is a provider of technology-enabled revenue-cycle-management services to hospitals and health systems. Terms:
| Borrower | Ensemble Health Partners |
| Issue | $785 million fungible incremental first-lien term loan |
| UoP | Dividend recap |
| Spread | L+375 |
| LIBOR floor | 0% |
| Price | 99.75 |
| Tenor | August 2026 |
| YTM | 4.07% |
| Four-year yield | 4.08% |
| Call protection | 101 soft call for 6 months |
| Corporate ratings | B/B2 |
| Facility ratings | B/B2 |
| Recovery ratings | 3 |
| Financial covenants | None |
| Arrangers | GS/Antares/Citi/DB/Gugg/Miz |
| Admin agent | GS |
| Px Talk | L+375/0%/99 |
| Sponsor | Golden Gate Capital |
| Notes | Upsized by $100 million. |